Unique ID issued by UMIN | UMIN000024977 |
---|---|
Receipt number | R000028742 |
Scientific Title | The identification of molecular mechanisms and a new biomarker of pancreatic cancer with glucose intolerance. |
Date of disclosure of the study information | 2016/11/24 |
Last modified on | 2023/05/31 09:24:00 |
The identification of molecular mechanisms and a new biomarker of pancreatic cancer with glucose intolerance.
The identification of molecular mechanisms and a new biomarker of pancreatic cancer with glucose intolerance.
The identification of molecular mechanisms and a new biomarker of pancreatic cancer with glucose intolerance.
The identification of molecular mechanisms and a new biomarker of pancreatic cancer with glucose intolerance.
Japan |
Pancreatic cancer, Diabetes
Hepato-biliary-pancreatic medicine | Endocrinology and Metabolism | Hepato-biliary-pancreatic surgery |
Malignancy
NO
Patients who undergo pancreatectomy are classified into 4 groups according to glucose tolerance.
Blood and surgical specimen are obtained from each group.
The purpose is to analyse RNA expression profile and then examine molecular mechanisms by which pancreatic cancer promotes glucose intolerance.
Others
Identify a novel biomarker of pancreatic cancer.
Others
Others
Not applicable
Expression profile of coding and non- coding RNA obtained from pancreatic cancer patients' blood and surgical specimen.
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1.Pancreatic cancer patients who undergo a pancreatectomy operation in our hospital.
2.Pancreatic cancer without chemotherapy and radiation therapy.
1.Benign pancreatic disorder
2.Type 1 diabetes
3.Chronic pancreatitis
30
1st name | Jun |
Middle name | |
Last name | Wada |
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Department of Nephrology, Rheumatology, Endocrinology and Metabolism
700-8558
2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558 Japan
086-235-7235
junwada@okayama-u.ac.jp
1st name | Hiroko |
Middle name | |
Last name | Takahashi |
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Department of Nephrology, Rheumatology, Endocrinology and Metabolism
700-8558
2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558 Japan
086-235-7235
hirokotakahashi@okayama-u.ac.jp
Okayama University
Self funding
Self funding
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences and Okayama University Hospital, Ethics Committee
2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558 Japan
086-235-6503
mae6605@adm.okayama-u.ac.jp
NO
2016 | Year | 11 | Month | 24 | Day |
not released
Unpublished
not released
32
Specific substances were not detected.
2022 | Year | 11 | Month | 29 | Day |
Patients who had pancreatic cancer.
Pancreatic cancer tissues were obtained.
non
total RNA
Completed
2016 | Year | 11 | Month | 24 | Day |
2016 | Year | 10 | Month | 12 | Day |
2016 | Year | 11 | Month | 24 | Day |
2020 | Year | 09 | Month | 30 | Day |
prospective observational study
2016 | Year | 11 | Month | 24 | Day |
2023 | Year | 05 | Month | 31 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028742